@article {Bergmann-Leitner:1 November 2001:1381-6128:i,
	author = "Bergmann-Leitner, E.S.",
	title = "Preface",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "i-ii(1)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00001"
	doi = "doi:10.2174/1381612013397195"
}

@article {Brandes:1 November 2001:1381-6128:1553,
	author = "Brandes, A.A.",
	author = "Basso, U.",
	author = "Pasetto, L.M.",
	author = "Ermani, M.",
	title = "New Strategy Developments in Brain Tumor Therapy",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1553-1580(28)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00002"
	doi = "doi:10.2174/1381612013397221"
}

@article {Adjei:1 November 2001:1381-6128:1581,
	author = "Adjei, A.A.",
	title = "Ras Signaling Pathway Proteins as Therapeutic Targets",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1581-1594(14)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00003"
	doi = "doi:10.2174/1381612013397258"
}

@article {Frenkel:1 November 2001:1381-6128:1595,
	author = "Frenkel, G.D.",
	author = "Caffrey, P.B.",
	title = "A Prevention Strategy for Circumventing Drug Resistance in Cancer Chemotherapy",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1595-1614(20)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00004"
	doi = "doi:10.2174/1381612013397186"
}

@article {Robert:1 November 2001:1381-6128:1615,
	author = "Robert, E.G.",
	author = "Hunt, J.D.",
	title = "Lipid Messengers as Targets for Antiangiogenic Therapy",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1615-1626(12)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00005"
	doi = "doi:10.2174/1381612013397203"
}

@article {Uckun:1 November 2001:1381-6128:1627,
	author = "Uckun, F.M.",
	title = "Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1627-1639(13)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00006"
	doi = "doi:10.2174/1381612013397177"
}

@article {Leitner:1 November 2001:1381-6128:1641,
	author = "Leitner, W.W.",
	author = "Hammerl, P.",
	author = "Thalhamer, J.",
	title = "Nucleic Acid for the Treatment of Cancer: Genetic Vaccines and DNA Adjuvants",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1641-1667(27)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00007"
	doi = "doi:10.2174/1381612013397249"
}

@article {Roy:1 November 2001:1381-6128:1669,
	author = "Roy, K.K.",
	author = "Sausville, E.A.",
	title = "Early Development of Cyclin Dependent Kinase Modulators",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1669-1687(19)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00008"
	doi = "doi:10.2174/1381612013397230"
}

@article {Frank:1 November 2001:1381-6128:1689,
	author = "Frank, S.",
	author = "Ebert, A.D.",
	title = "License to Kill Tumors: How Much Hope is Justified for Trail",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 November 2001",
	pages = "1689-1701(13)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00009"
	doi = "doi:10.2174/1381612013397212"
}